Advertisement
Screener

Crinetics Pharmaceuticals, Inc. (CRNX) Operating Income

Crinetics Pharmaceuticals, Inc. Operating Income

Crinetics Pharmaceuticals, Inc. (CRNX) reported Operating Income of -$132.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-03

  • Crinetics Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$132.46M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$140.38M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$133.67M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$142.59M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for fiscal 2025 was -$516.77M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for fiscal 2024 was -$338.85M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for fiscal 2023 was -$222.61M.
  • Crinetics Pharmaceuticals, Inc. operating income (loss) for fiscal 2022 was -$167.88M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$132.46M
10-Q · filed 2026-08-03
-$272.84M
10-Q · filed 2026-08-03
-$406.50M
derived: sum of 3 quarters · filed 2026-08-03
-$549.09M
derived: sum of 4 quarters · filed 2026-08-03
2026-03-31-$140.38M
10-Q · filed 2026-05-07
-$274.04M
derived: sum of 2 quarters · filed 2026-05-07
-$416.63M
derived: sum of 3 quarters · filed 2026-05-07
-$545.74M
derived: sum of 4 quarters · filed 2026-08-03
2025-12-31-$133.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$276.25M
derived: sum of 2 quarters · filed 2026-02-26
-$405.36M
derived: sum of 3 quarters · filed 2026-08-03
-$516.77M
10-K · filed 2026-02-26
2025-09-30-$142.59M
10-Q · filed 2025-11-06
-$271.70M
derived: sum of 2 quarters · filed 2026-08-03
-$383.10M
10-Q · filed 2025-11-06
-$477.85M
derived: sum of 4 quarters · filed 2026-08-03
2025-06-30-$129.11M
10-Q · filed 2026-08-03
-$240.52M
10-Q · filed 2026-08-03
-$335.26M
derived: sum of 3 quarters · filed 2026-08-03
-$423.06M
derived: sum of 4 quarters · filed 2026-08-03
2025-03-31-$111.41M
10-Q · filed 2026-05-07
-$206.15M
derived: sum of 2 quarters · filed 2026-05-07
-$293.95M
derived: sum of 3 quarters · filed 2026-05-07
-$376.73M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$94.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$182.54M
derived: sum of 2 quarters · filed 2026-02-26
-$265.32M
derived: sum of 3 quarters · filed 2026-02-26
-$338.85M
10-K · filed 2026-02-26
2024-09-30-$87.80M
10-Q · filed 2025-11-06
-$170.58M
derived: sum of 2 quarters · filed 2025-11-06
-$244.11M
10-Q · filed 2025-11-06
-$306.77M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$82.78M
10-Q · filed 2025-08-07
-$156.31M
10-Q · filed 2025-08-07
-$218.97M
derived: sum of 3 quarters · filed 2026-02-26
-$277.95M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$73.53M
10-Q · filed 2025-05-08
-$136.19M
derived: sum of 2 quarters · filed 2026-02-26
-$195.16M
derived: sum of 3 quarters · filed 2026-02-26
-$248.16M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$62.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$121.64M
derived: sum of 2 quarters · filed 2026-02-26
-$174.63M
derived: sum of 3 quarters · filed 2026-02-26
-$222.61M
10-K · filed 2026-02-26
2023-09-30-$58.98M
10-Q · filed 2024-11-12
-$111.97M
derived: sum of 2 quarters · filed 2024-11-12
-$159.95M
10-Q · filed 2024-11-12
-$207.51M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$52.99M
10-Q · filed 2024-08-08
-$100.97M
10-Q · filed 2024-08-08
-$148.53M
derived: sum of 3 quarters · filed 2025-02-27
-$191.98M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$47.98M
10-Q · filed 2024-05-09
-$95.53M
derived: sum of 2 quarters · filed 2025-02-27
-$138.99M
derived: sum of 3 quarters · filed 2025-02-27
-$182.03M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$47.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$91.01M
derived: sum of 2 quarters · filed 2025-02-27
-$134.06M
derived: sum of 3 quarters · filed 2025-02-27
-$167.88M
10-K · filed 2025-02-27
2022-09-30-$43.45M
10-Q · filed 2023-11-07
-$86.50M
derived: sum of 2 quarters · filed 2023-11-07
-$120.33M
10-Q · filed 2023-11-07
-$151.21M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$43.05M
10-Q · filed 2023-08-08
-$76.87M
10-Q · filed 2023-08-08
-$107.76M
derived: sum of 3 quarters · filed 2024-02-28
-$135.57M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$33.83M
10-Q · filed 2023-05-09
-$64.72M
derived: sum of 2 quarters · filed 2024-02-28
-$92.52M
derived: sum of 3 quarters · filed 2024-02-28
-$118.61M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$30.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$58.70M
derived: sum of 2 quarters · filed 2024-02-28
-$84.78M
derived: sum of 3 quarters · filed 2024-02-28
-$107.70M
10-K · filed 2024-02-28
2021-09-30-$27.81M
10-Q · filed 2022-11-14
-$53.90M
derived: sum of 2 quarters · filed 2022-11-14
-$76.81M
10-Q · filed 2022-11-14
-$98.61M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$26.09M
10-Q · filed 2022-08-12
-$49.01M
10-Q · filed 2022-08-12
-$70.80M
derived: sum of 3 quarters · filed 2023-02-28
-$89.25M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$22.92M
10-Q · filed 2022-05-12
-$44.71M
derived: sum of 2 quarters · filed 2023-02-28
-$63.16M
derived: sum of 3 quarters · filed 2023-02-28
-$80.09M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$21.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$40.24M
derived: sum of 2 quarters · filed 2023-02-28
-$57.17M
derived: sum of 3 quarters · filed 2023-02-28
-$74.95M
10-K · filed 2023-02-28
2020-09-30-$18.45M
10-Q · filed 2021-11-05
-$35.38M
derived: sum of 2 quarters · filed 2021-11-05
-$53.16M
10-Q · filed 2021-11-05
-$68.38M
derived: sum of 4 quarters · filed 2022-03-30
2020-06-30-$16.93M
10-Q · filed 2021-08-10
-$34.71M
10-Q · filed 2021-08-10
-$49.92M
derived: sum of 3 quarters · filed 2022-03-30
-$65.15M
derived: sum of 4 quarters · filed 2022-03-30
2020-03-31-$17.78M
10-Q · filed 2021-05-06
-$33.00M
derived: sum of 2 quarters · filed 2022-03-30
-$48.23M
derived: sum of 3 quarters · filed 2022-03-30
-$61.57M
derived: sum of 4 quarters · filed 2022-03-30
2019-12-31-$15.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$30.44M
derived: sum of 2 quarters · filed 2022-03-30
-$43.79M
derived: sum of 3 quarters · filed 2022-03-30
-$53.83M
10-K · filed 2022-03-30
2019-09-30-$15.23M
10-Q · filed 2020-11-06
-$28.57M
derived: sum of 2 quarters · filed 2020-11-06
-$38.62M
10-Q · filed 2020-11-06
-$48.05M
derived: sum of 4 quarters · filed 2021-03-30
2019-06-30-$13.35M
10-Q · filed 2020-08-07
-$23.39M
10-Q · filed 2020-08-07
-$32.82M
derived: sum of 3 quarters · filed 2021-03-30
-$40.89M
derived: sum of 4 quarters · filed 2021-03-30
2019-03-31-$10.04M
10-Q · filed 2020-05-08
-$19.48M
derived: sum of 2 quarters · filed 2021-03-30
-$27.55M
derived: sum of 3 quarters · filed 2021-03-30
-$33.23M
derived: sum of 4 quarters · filed 2021-03-30
2018-12-31-$9.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
-$17.50M
derived: sum of 2 quarters · filed 2021-03-30
-$23.18M
derived: sum of 3 quarters · filed 2021-03-30
-$28.71M
10-K · filed 2021-03-30
2018-09-30-$8.07M
10-Q · filed 2019-11-12
-$13.75M
derived: sum of 2 quarters · filed 2019-11-12
-$19.28M
10-Q · filed 2019-11-12
-$21.78M
derived: sum of 4 quarters · filed 2020-03-09
2018-06-30-$5.68M
10-Q · filed 2019-08-13
-$11.21M
10-Q · filed 2019-08-13
-$13.71M
derived: sum of 3 quarters · filed 2020-03-09
-$16.08M
derived: sum of 4 quarters · filed 2020-03-09
2018-03-31-$5.53M
10-Q · filed 2019-05-13
-$8.03M
derived: sum of 2 quarters · filed 2020-03-09
-$10.40M
derived: sum of 3 quarters · filed 2020-03-09
-$12.04M
derived: sum of 4 quarters · filed 2020-03-09
2017-12-31-$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
-$4.88M
derived: sum of 2 quarters · filed 2020-03-09
-$6.52M
derived: sum of 3 quarters · filed 2020-03-09
-$9.13M
10-K · filed 2020-03-09
2017-09-30-$2.37M
10-Q · filed 2018-11-13
-$4.02M
derived: sum of 2 quarters · filed 2018-11-13
-$6.63M
10-Q · filed 2018-11-13
2017-06-30-$1.64M
10-Q · filed 2018-08-30
-$4.25M
10-Q · filed 2018-08-30
2016-12-31-$6.04M
10-K · filed 2019-03-13